Baseline (n = 56) | Follow-up (n = 61) | ||||
---|---|---|---|---|---|
n | % | n | % | p-valuea | |
Survey Response per regional network, Mdn (Range) | 3 | 1–7 | 3 | 0–8 | |
Age: | 0.92 | ||||
25–34 | 11 | 19.6 | 11 | 18.6 | |
35–44 | 20 | 35.7 | 18 | 30.5 | |
45–54 | 12 | 21.4 | 15 | 25.4 | |
55–64 | 9 | 16.1 | 12 | 20.3 | |
65 + | 4 | 7.1 | 3 | 5.1 | |
Gender: | 0.81 | ||||
Female | 33 | 58.9 | 34 | 56.7 | |
Male | 23 | 41.1 | 26 | 43.3 | |
Total years of practice: | 0.70 | ||||
≤ 5 | 9 | 16.1 | 6 | 9.8 | |
5–10 | 14 | 25.0 | 19 | 31.1 | |
11–20 | 15 | 26.8 | 18 | 29.5 | |
20 + | 18 | 32.1 | 18 | 29.5 | |
Race/Ethnicity: | 0.52 | ||||
Asian | 9 | 16.4 | 7 | 11.7 | |
Black or African American | 5 | 9.1 | 6 | 10.0 | |
Hispanic or Latino | 4 | 7.3 | 1 | 1.7 | |
Multiple ethnicity / Other | 4 | 7.3 | 7 | 11.7 | |
White/Caucasian | 33 | 60.0 | 39 | 65.0 | |
Discipline: | 0.58 | ||||
Physician | 18 | 32.1 | 25 | 41.7 | |
Nurse Practitioner | 8 | 14.3 | 4 | 6.7 | |
Psychologist/Social Worker/Addictions Therapist | 10 | 17.9 | 9 | 15.0 | |
Pharmacist | 9 | 16.1 | 12 | 20.0 | |
Nurse | 11 | 19.6 | 10 | 16.7 | |
Specialty: | 0.98 | ||||
Mental Health | 21 | 37.5 | 25 | 41.0 | |
Pain Management | 16 | 28.6 | 17 | 27.9 | |
Primary care/general internal medicine | 16 | 28.6 | 16 | 26.2 | |
Multiple or Other | 3 | 5.4 | 3 | 4.9 | |
Provider: Prescriber | 26 | 46.4 | 28 | 45.9 | 0.95 |
DEA Waivered | 21 | 80.8 | 27 | 96.4 | 0.07 |
Prescribed Buprenorphine for OUD past year | 13 | 61.9 | 20 | 74.1 | 0.37 |